Structural analysis of 5'-mRNA-cap interactions with the human AGO2 MID domain

EMBO Rep. 2011 May;12(5):415-20. doi: 10.1038/embor.2011.48. Epub 2011 Apr 8.

Abstract

In RNA silencing, microRNA (miRNA)-mediated translational repression occurs through mechanisms that do not invoke messenger-RNA (mRNA) target cleavage by Argonaute proteins. The nature of these mechanisms is unclear, but several recent studies have proposed that a direct interaction between the mRNA-cap and the middle (MID) domain of Argonautes is involved. Here, we present crystallographic and NMR data demonstrating that cap analogues do not bind significantly to the isolated MID domain of human Argonaute 2 (hAGO2) and are found in the miRNA 5'-nucleotide binding site in an implausible binding mode. Additionally, in vitro pull-down experiments with full-length hAGO2 indicate that the interaction with cap analogues is nonspecific.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Argonaute Proteins
  • Biophysics
  • Crystallography
  • Eukaryotic Initiation Factor-2 / genetics
  • Eukaryotic Initiation Factor-2 / metabolism*
  • Humans
  • Magnetic Resonance Spectroscopy
  • Models, Molecular*
  • Protein Binding*
  • Protein Conformation*
  • Protein Structure, Tertiary / genetics*
  • RNA Caps / genetics
  • RNA Caps / metabolism*
  • RNA Interference*

Substances

  • AGO2 protein, human
  • Argonaute Proteins
  • Eukaryotic Initiation Factor-2
  • RNA Caps